Assignee
JANSSEN ALZHEIMER IMMUNOTHERAP
IE·14 granted patents·4 pending applications·494 citations·filing 1999–2014
Top patents by PatentIndex Score
18 records- 0197US7893214B2Humanized antibodies that recognize beta amyloid peptideJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2007·Granted Feb 22, 2011·41 cites·4 claims
- 0296US7700751B2Humanized antibodies that recognize β-amyloid peptideJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2007·Granted Apr 20, 2010·38 cites·86 claims
- 0396US7625560B2Humanized antibodies that recognize beta amyloid peptideJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2005·Granted Dec 1, 2009·73 cites·22 claims
- 0495US8034339B2Prevention and treatment of amyloidogenic diseaseJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2004·Granted Oct 11, 2011·33 cites·41 claims
- 0594US7790856B2Humanized antibodies that recognize beta amyloid peptideJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2006·Granted Sep 7, 2010·26 cites·9 claims
- 0694US7635473B2Anti Aβ antibody formulationJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2006·Granted Dec 22, 2009·52 cites·28 claims
- 0792US7820799B2Methods of purifying Fc region containing proteinsJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2006·Granted Oct 26, 2010·41 cites·86 claims
- 0892US7727957B2Treatment and delay of outset of Parkinson's diseaseJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2003·Granted Jun 1, 2010·44 cites·24 claims
- 0991US8034348B2Prevention and treatment of amyloidogenic diseaseJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2007·Granted Oct 11, 2011·9 cites·20 claims
- 1091US8003097B2Treatment of cerebral amyloid angiopathyJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2008·Granted Aug 23, 2011·41 cites·13 claims
- 1190US7871615B2Humanized antibodies that recognize beta amyloid peptideJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2004·Granted Jan 18, 2011·46 cites·32 claims
- 1286US7825223B2Methods of purifying anti A β antibodiesJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2006·Granted Nov 2, 2010·10 cites·96 claims
- 1384US7964192B1Prevention and treatment of amyloidgenic diseaseJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 1999·Granted Jun 21, 2011·37 cites·63 claims
- 1470US8357781B2Neuroactive fragments of APPJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2007·Granted Jan 22, 2013·3 cites·2 claims
- 1564US2014341911A1Prevention and Treatment of Amyloidogenic DiseaseJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2014·Application pending·0 cites
- 1648US2015353631A1C-terminal and central epitope a-beta antibodiesJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2013·Application pending·0 cites
- 1743US2011135660A1Prevention and treatment of synucleinopathic diseaseJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2010·Application pending·0 cites
- 1832US2013273574A1Oligomeric a-beta in the diagnosis, prognosis, and monitoring of alzheimer's diseaseJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when JANSSEN ALZHEIMER IMMUNOTHERAP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →